1Fahn S. The spectrum of levodopa - induced dyskinesia. Ann Neurol, 2000 ; 47 (4 Suppl 1 ) : S2.
2Hallett M. Clinical physiology of dopa dyskinesia. Ann Neurol,2000;47(4 Suppl 1):S147.
3Obeso JA, Rodriguez- Oroz MC. Rodriguez M, et al. Pathophysiology of levodopa - induced dyskinesia in Parkinson' s disease: problems with the current model. Ann Neurol,2000;47(4 Suppl 1) :S22.
4Brotchie JM. The neural mechanisms underlying levodopainduced dyskinesia in Parkinson' s disease. Ann Neurol,2000;47(4 Suppl 1) :S105.
5Brooks DJ, Piccini P, Turjanski N, et al. Neuroimaging of dyskinesia. Ann Neurol,2000 ;47(4 Suppl 1 ) :S154.
6Hirsch EC. Nigrostriatal system plasticity in Parkinson' s disease: effect of dopaminergic denervation and treatment.Ann Neurol,2000;47(4 Suppl 1) :S115 - 120.
7Calon F, Grondin R, Morissette M, et al. Molecular basis of levodopa - induced dyskinesia. Ann Neurol,2000 ; 47 (4 Suppl 1 ) : S70.
8Calon F, Birdi S, Rajput AH, et al. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levo - dopa - induced dysklnesias. J Neuropathol, 2002 ; 61920; 186.
9Jenner P. Factors influencing the onset and persistence of dyskinesia in MPTP - treated primates. Ann Neurol, 2000 ;47(4 Suppl 1):S90.
2Schrag A,Jahanshahi M,Quinn N.Dyskinesias and motor fluctuations in Parkinson's disease.A community-based study[J].Brain,2000,123(Pt 11):2297-2305.
3Ahlskog JE,Muenter MD.Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature[J].Mov Disord,2001,16(3):448-458.
4Stefani A,Bassi A,Mazzone P,et al.Subdyskinetia apomombine responases in globus pallidus and subthalamus of Parkinsonian patients:lack of clear evidence for the indirect pathway[J].Clin Neurophysiol,2002,113(1):91.
